Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs).
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has increased by 1.35%
1 month ago•Bloomberg Quint
1 month ago•Business Standard
1 month ago•Economic Times
Aurobindo Pharma Limited has informed the Exchange regarding 'New injectable facility of Eugia Steriles Private Limited, a 100% stepdown subsidiary of the Company, receives its first product approval by the United States Food and Drug Administration (US FDA)'. | Download
Aurobindo Pharma Limited has informed the Exchange regarding 'New injectable facility of Eugia Steriles Private Limited, a 100% stepdown subsidiary of the Company, receives its first product approval by the United States Food and Drug Administration (US FDA)'. | Download
Interim 2 • Div/Share: ₹ 1.5
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant